A detailed history of Primecap Management CO transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Primecap Management CO holds 5,670,226 shares of ALLO stock, worth $15.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,670,226
Previous 5,448,386 4.07%
Holding current value
$15.2 Million
Previous $24.4 Million 45.75%
% of portfolio
0.01%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.23 - $4.38 $494,703 - $971,659
221,840 Added 4.07%
5,670,226 $13.2 Million
Q1 2024

May 13, 2024

BUY
$2.92 - $5.63 $486,180 - $937,395
166,500 Added 3.15%
5,448,386 $24.4 Million
Q4 2023

Feb 09, 2024

SELL
$2.28 - $3.5 $5,699 - $8,750
-2,500 Reduced 0.05%
5,281,886 $17 Million
Q3 2023

Nov 13, 2023

SELL
$3.17 - $5.96 $1.12 Million - $2.1 Million
-352,300 Reduced 6.25%
5,284,386 $16.8 Million
Q2 2023

Aug 11, 2023

SELL
$4.53 - $6.74 $599,319 - $891,702
-132,300 Reduced 2.29%
5,636,686 $28 Million
Q1 2023

May 15, 2023

BUY
$4.92 - $8.21 $4.06 Million - $6.77 Million
825,070 Added 16.69%
5,768,986 $28.5 Million
Q4 2022

Feb 13, 2023

BUY
$5.62 - $11.11 $286,901 - $567,165
51,050 Added 1.04%
4,943,916 $31.1 Million
Q3 2022

Nov 14, 2022

BUY
$10.32 - $17.28 $102,168 - $171,072
9,900 Added 0.2%
4,892,866 $52.8 Million
Q2 2022

Aug 11, 2022

SELL
$6.78 - $12.28 $157,974 - $286,124
-23,300 Reduced 0.47%
4,882,966 $55.7 Million
Q1 2022

May 11, 2022

BUY
$7.65 - $15.29 $1.87 Million - $3.74 Million
244,451 Added 5.24%
4,906,266 $44.7 Million
Q4 2021

Feb 11, 2022

BUY
$13.13 - $24.52 $13.9 Million - $25.9 Million
1,057,515 Added 29.34%
4,661,815 $69.6 Million
Q3 2021

Nov 12, 2021

BUY
$21.01 - $27.64 $572,942 - $753,742
27,270 Added 0.76%
3,604,300 $92.6 Million
Q2 2021

Aug 10, 2021

BUY
$23.49 - $35.8 $53.4 Million - $81.3 Million
2,271,630 Added 174.02%
3,577,030 $93.3 Million
Q1 2021

May 14, 2021

BUY
$25.79 - $39.02 $1.73 Million - $2.61 Million
67,000 Added 5.41%
1,305,400 $46.1 Million
Q4 2020

Feb 08, 2021

BUY
$25.24 - $43.45 $31.3 Million - $53.8 Million
1,238,400 New
1,238,400 $31.3 Million

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $385M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.